AMRX Stock Price, Chart, Stats & News

Amneal Pharmaceuticals, Inc.
Save
5.29B
Market cap
44.78x
Current P/E
6.30x
Forward P/E
AMRX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 36.88% |
Operating margin | 10.80% |
Pretax margin | 4.61% |
Net margin | 2.39% |
Effective tax rate | 8.10% |
ROA | 1.96% |
ROE | -67.91% |
D/E | -38.65x |
Interest coverage ratio | 1.35x |
AMRX valuation
P/E | 44.78x |
P/S | 1.24x |
P/B | -52.45x |
P/CF | 10.92x |
P/FCF | 15.73x |
P/OCF | 10.92x |
PEG | 0.04x |
EV multiple | 2.16x |
About
Amneal Pharmaceuticals, Inc., operating alongside its various subsidiaries, is a diversified pharmaceutical company involved in the development, acquisition of licenses, manufacturing, marketing, and distribution of both generic and specialized medicinal products. These offerings span a multitude of delivery formats and target a wide range of therapeutic needs. Its operations are structured into three distinct divisions: Generics, Specialty, and AvKARE.
Similar securities
Based on sector and market capitalization
Report issue











